Your browser is no longer supported. Please, upgrade your browser.
Settings
AVDL Avadel Pharmaceuticals plc daily Stock Chart
AVDL [NASD]
Avadel Pharmaceuticals plc
Index- P/E31.35 EPS (ttm)0.31 Insider Own2.50% Shs Outstand41.53M Perf Week0.93%
Market Cap406.16M Forward P/E54.94 EPS next Y0.18 Insider Trans- Shs Float40.52M Perf Month-1.31%
Income30.10M PEG- EPS next Q-0.30 Inst Own70.20% Short Float1.49% Perf Quarter-6.86%
Sales150.50M P/S2.70 EPS this Y138.00% Inst Trans-2.97% Short Ratio6.52 Perf Half Y-30.83%
Book/sh0.89 P/B10.99 EPS next Y112.00% ROA12.40% Target Price16.00 Perf Year1.35%
Cash/sh3.60 P/C2.71 EPS next 5Y- ROE52.90% 52W Range7.56 - 15.45 Perf YTD-5.87%
Dividend- P/FCF11.28 EPS past 5Y35.30% ROI20.10% 52W High-36.70% Beta1.39
Dividend %- Quick Ratio2.90 Sales past 5Y36.10% Gross Margin91.30% 52W Low29.37% ATR0.45
Employees109 Current Ratio3.00 Sales Q/Q-32.10% Oper. Margin36.50% RSI (14)49.12 Volatility4.17% 4.82%
OptionableYes Debt/Eq4.02 EPS Q/Q29.80% Profit Margin20.00% Rel Volume0.56 Prev Close9.85
ShortableYes LT Debt/Eq4.01 EarningsMar 07 BMO Payout0.00% Avg Volume92.81K Price9.78
Recom1.70 SMA20-0.11% SMA50-3.32% SMA200-13.58% Volume52,390 Change-0.71%
Feb-16-17 06:37AM  AVADEL PHARMACEUTICALS PLC Files SEC form 8-K, Other Events
Feb-14-17 07:30AM  Avadel Pharmaceuticals to Report Fourth Quarter and Full Year 2016 Results GlobeNewswire
Feb-06-17 03:55PM  AVADEL PHARMACEUTICALS PLC Files SEC form 8-K, Other Events
07:30AM  Avadel Pharmaceuticals to Present at Two Upcoming Investor Conferences GlobeNewswire
Jan-11-17 04:05PM  AVADEL PHARMACEUTICALS PLC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
Jan-06-17 01:52PM  AVADEL PHARMACEUTICALS PLC Files SEC form 8-K, Other Events -6.66%
01:04PM  AVADEL PHARMACEUTICALS PLC Financials
Jan-05-17 11:57AM  AVADEL PHARMACEUTICALS PLC Files SEC form 8-K, Other Events, Financial Statements and Exhibits +5.18%
08:18AM  CORRECTING and REPLACING Avadel Pharmaceuticals Provides 2017 Guidance and Business Update GlobeNewswire
07:30AM  Avadel Pharmaceuticals Provides 2017 Guidance and Business Update GlobeNewswire
Jan-03-17 04:03PM  Avadel Pharmaceuticals Appoints Gregory J. Divis Chief Commercial Officer GlobeNewswire +5.39%
07:30AM  Flamel Technologies Completes Cross-Border Merger and Becomes Avadel Pharmaceuticals plc GlobeNewswire
Dec-19-16 03:38PM  FLAMEL TECHNOLOGIES SA Files SEC form 8-K, Other Events
Avadel Pharmaceuticals PLC is a pharmaceutical company engaged in drug delivery and formulation development to create safer and more efficacious pharmaceutical products.